Acumen Pharmaceuticals
ABOS
ABOS
53 hedge funds and large institutions have $127M invested in Acumen Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
Holders
53
Holding in Top 10
2
Calls
$1.66M
Puts
$611K
Top Buyers
| 1 | +$2.41M | |
| 2 | +$1.92M | |
| 3 | +$431K | |
| 4 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$361K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$301K |
Top Sellers
| 1 | -$2.23M | |
| 2 | -$1.73M | |
| 3 | -$1.62M | |
| 4 |
BlackRock
New York
|
-$906K |
| 5 |
Walleye Capital
New York
|
-$798K |